Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 17/20 | 0.56 |
| ▸ | PPARG | P37231 | 17/20 | 0.56 |
| ▸ | PPARD | Q03181 | 9/20 | 0.56 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.48 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6572462 | 0.92 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL6572905 | 0.90 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL6574440 | 0.89 | PPARG (0.70) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL5379986 | 0.84 | PPARG (0.73) | PPARAPPARGPPARD | |
| SCHEMBL5381781 | 0.83 | PPARA (0.68) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL6574322 | 0.80 | PPARA (0.70) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL5392011 | 0.80 | PPARG (0.70) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL5375703 | 0.80 | PPARG (0.70) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL14560737 | 0.79 | PPARA (0.59) | PPARAPPARGPPARDSRRPSAT1 | |
| SCHEMBL6571555 | 0.78 | PPARA (0.71) | PPARAPPARGPPARDSRRPSAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392637-A2 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | ELI LILLY AND COMPANY (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002100813-A2 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | ELI LILLY AND COMPANY (US) | 2002-12-19 | — | — | WO | disclosed |